Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study
Year: 2020
Type: article
Study design: Observational Study
Abstract: Objective To determine the joint role of ideal cardiovascular health (CVH) and genetic risk on risk of dementia. Methods We categorized CVH on the basis of the American Heart Association Ideal CVH Index and genetic risk through a genetic risk score (GRS) of common genetic variants and the APOE ε4 genotype in 1,211 Framingham Heart Study (FHS) offspring cohort participants. We used multivariable Cox proportional hazards regression models to examine the association between CVH, genetic risk, and incident all-cause dementia with up to 10 years of follow-up (mean 8.4 years, 96 incident dementia cases), adjusting for age, sex, and education. Results We observed that a high GRS (>80th percentile) was associated with a 2.6-fold risk of dementia (95% confidence interval [CI] of hazard ratio [HR] 1.23–5.29; p = 0.012) compared with having a low GRS (<20th percentile); carrying at least 1 APOE ε4 allele was associated with a 2.3-fold risk of dementia compared with not carrying an APOE ε4 allele (95% CI of HR 1.49–3.53; p = 0.0002), and having a favorable CVH showed a 0.45-fold lower risk of dementia (95% CI of HR 0.20–1.01; p = 0.0527) compared to having an unfavorable CVH when all 3 components were included in the model. We did not observe an interaction between CVH and GRS (p = 0.99) or APOE ε4 (p = 0.16). Conclusions We observed that both genetic risk and CVH contribute additively to dementia risk.
Source: Neurology
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: CHARGE: Identifying Risk & Protective SNV for AD in ADSP Case-control Sample, Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium, G278200998, G3405256882, G36937976, ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems, G4976486911, Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham Cohorts, G5164707915, Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults, The Framingham Heart Study, SNP HEALTH ASSOCIATION RESOURCE (SHARE), AD Gene Discovery: Exome Chip, New Endophenotypes & Functional Studies in CHARGE, Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC), Precursors of Stroke Incidence and Prognosis
OpenAlex ID: W3044539294
